Online Only Articles

Mutational status of IGHV is the most reliable prognostic marker in trisomy 12 chronic lymphocytic leukemia

Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy
Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy
Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy
Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy
Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy
Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy
Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy
Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy
Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy
Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy
Division of Hematology – Department of Translational Medicine – Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Division of Hematology, Ferrarotto Hospital, Catania, Italy
Department of Hematology, Mayo Clinic, Rochester, MN, USA
Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland
IRCCS, Referral Cancer Center of Basilicata, Potenza, Italy
Oncologia Medica A IRCCS, Centro di Riferimento Oncologico, Aviano, Italy
Clinica Ematologica, Centro Trapianti e Terapie Cellulari “Carlo Melzi” DISM, Azienda Ospedaliera Universitaria S. Maria Misericordia, Udine, Italy
Department of Internal Medicine and Hematology, Maggiore General Hospital, University of Trieste, Italy
Division of Hematology, Ferrarotto Hospital, Catania, Italy
Oncology Institute of Southern Switzerland (IOSI), Bellinzona, Switzerland
Division of Hematology, S. Eugenio Hospital and University of Tor Vergata, Rome, Italy
Division of Hematology – Department of Translational Medicine – Amedeo Avogadro University of Eastern Piedmont, Novara, Italy
Department of Hematology, Mayo Clinic, Rochester, MN, USA
Clinical and Experimental Onco-Hematology Unit, IRCCS Centro di Riferimento Oncologico, Aviano, Italy
Vol. 102 No. 11 (2017): November, 2017 https://doi.org/10.3324/haematol.2017.170340